Depression, Anxiety, and Alcohol Use Among LGBTQ plus People During the COVID-19 Pandemic
Depression, Anxiety, and Alcohol Use Among LGBTQ plus People During the COVID-19 Pandemic
复制标题
DOI：
10.2105/ajph.2021.306394
复制
发表时间：
2021-09-01
影响因子：
12.7
通讯作者：
Chae, David H.
中科院分区：
文献类型：
--
作者：
Akre, Ellesse-Roselee;Anderson, Andrew;Chae, David H.
目标。从性取向、性行为和性别认同三个方面描述新冠肺炎期间抑郁、焦虑和问题饮酒的差异。数据收集于2020年5月21日至7月15日，来自美国5个主要大都市地区(佐治亚州亚特兰大、伊利诺伊州芝加哥、路易斯安那州新奥尔良、纽约纽约和加利福尼亚州洛杉矶)的3245名成年人。参与者被描述为顺性直或LGBTQ+(即女同性恋者、男同性恋者、双性恋者和变性者，以及与男性发生性关系的男性，以及与不认为自己是女同性恋者、男同性恋者、双性恋者或变性人的女性发生性关系的女性)。与所有其他性取向、性行为和性别认同组相比，顺性异性恋参与者的抑郁、焦虑和饮酒问题水平最低，总体而言，LGBTQ+参与者更有可能报告这些健康问题在新冠肺炎期间比平时更严重。在新冠肺炎大流行期间，LGBTQ+社区的心理健康和饮酒问题比他们的顺性异性恋社区更糟糕。未来的研究应该评估大流行对卫生不平等的影响。政策制定者应该考虑提供资源，支持LGBTQ+心理健康和新冠肺炎恢复工作中的物质使用预防。
Objectives. To describe disparities in depression, anxiety, and problem drinking by sexual orientation, sexual behavior, and gender identity during the COVID-19 pandemic.Methods. Data were collected May 21 to July 15, 2020, from 3245 adults living in 5 major US metropolitan areas (Atlanta, Georgia; Chicago, Illinois; New Orleans, Louisiana; New York, New York; and Los Angeles, California). Participants were characterized as cisgender straight or LGBTQ+ (i.e., lesbian, gay, bisexual, and transgender people, and men who have sex with men, and women who have sex with women not identifying as lesbian, gay, bisexual, or transgender).Results. Cisgender straight participants had the lowest levels of depression, anxiety, and problem drinking compared with all other sexual orientation, sexual behavior, and gender identity groups, and, in general, LGBTQ+ participants were more likely to report that these health problems were "more than usual" during the COVID-19 pandemic.Conclusions. LGBTQ+ communities experienced worse mental health and problem drinking than their cisgender straight counterparts during the COVID-19 pandemic. Future research should assess the impact of the pandemic on health inequities. Policymakers should consider resources to support LGBTQ+ mental health and substance use prevention in COVID-19 recovery efforts.